“showed a trend”

While our data showed a trend of slightly lower protective behavior among those who received three doses compared to those who received two doses, this was not statistically significant.

These differences were no longer significant in adulthood, and in older animals, dspb −/− hearts showed a trend to increased size compared with wt hearts (Fig. 5 a-b; Table S4).

In the hind limbs, the difference in relative bone shortening between long bones (10.9%) and metatarsals (15.3%) showed a trend but did not reach statistical significance ( P = 0.065) ( Figure 6 , C and D).

Mice treated with anti-αTim-3 mAb showed a trend toward increased expression of the P2RY12 protein in microglia.

While the VR platform showed a trend toward being rated as easier to use overall (Q3: mean 4.07 vs. 3.27), Both platforms were rated similarly for critical surgical planning considerations.

Third, group 2 participants, who experienced a moderate level of baseline social support, showed significantly more severe PTSD symptoms than group 4 did, while group 1 (low baseline support) showed a trend toward an increase in PTSD symptoms.

In patients with RMS, an incomplete B-cell depletion or higher B-cell counts in blood before the next infusion showed a trend toward elevated risk of disease progression [ 77 ].

Similar observations have been made across products and indications: in patients treated with tisagenlecleucel, for example, CD19-dim B-ALL cases showed a trend toward a higher rate of failure to achieve deep remission (Pillai et al, 2019 ).

Total parathyroidectomy showed a trend toward fewer failures than subtotal parathyroidectomy.

INR (OR 5.23; 95% CI: 0.99, 27.62; p = 0.051) and hsTrop-I (OR 1.49; 95% CI: 0.99, 2.24; p = 0.053) also showed a trend towards predicting 30-day mortality.

Kellgren–Lawrence grade showed a trend toward higher odds of lympho-myeloid infiltration (OR 1.54, 95% CI 0.96–2.51) but did not reach statistical significance ( p = 0.074).

AF Classification: In the paroxysmal AF subgroup, the combined approach showed a trend toward higher procedural success (OR 0.75, 95% CI 0.36–1.57) and lower event-free survival (OR 0.60, 95% CI 0.34–1.05).

Notably, the trial showed a trend for greater benefit with an increasing number of previous miscarriages, generating the hypothesis that a subgroup effect existed with a biological gradient related to the increasing number of previous miscarriages. 20 2.2.

Behavioral testing at 2 months revealed that Kir2.1-expressing mice (injection of AAVs with Kir2.1 at P7) showed a trend toward decreased distance traveled and percentage time spent in center ( Figure 7L–N ).

Conclusion Compared with wideband PSIR, wideband SPOT showed a trend towards enhanced scar detection, identifying additional scarred segments while maintaining similar overall scar burden.

Alpha diversity for each individual sample, calculated using Chao1 index at genus level, showed a trend toward higher richness in black samples, although this difference was not statistically significant (Wilcoxon t ‐test, p = 0.4; Figure 3I,J ).

Atezolizumab combined with Entinostat and chemotherapy (Atezo-Entino-chemo) showed a trend toward improved OS (HR = 0.49, 95% CI: 0.22-1.12) and ORR (OR = 5.14, 95% CI: 0.70-37.94).

In the VKA/LMWH group without prior VKA treatment, protein C showed a trend toward decrease from baseline at week 2 and a statistically significant decrease at month 6 ( P =0.004).

Compared with alirocumab, statins showed a trend toward reduced risk of the primary composite outcome, which included cardiovascular death, MI, HF, stroke, and coronary revascularization.

Gene Set Enrichment Analysis (GSEA) of TCGA-EAC database, comparing PRDX2-high and PRDX2-low groups, showed a trend for enrichment of the deubiquitination pathway in the PRDX2-high group, despite a non-significant p-value.

In this sense, patients with hypocomplementemia showed a trend towards a lower number of pregnancies, as well as a higher frequency of early abortions and PE.

Regarding clinical outcomes, the ESPB group showed a trend towards shorter hospital length of stay.

Relative to control cells, exposure to CTK-2 showed a trend toward reduced complexity in the peak/early-decay region but did not reach significance in this dataset when tested per radius ( Figures 6E,F ).

Although not significant, the Ta/Tp MIS group also showed a trend toward fewer intraoperative complications than the non-Ta/Tp MIS group.

Repositioning times showed a trend towards improvement in first-to-best transfer attempts, median ∼35 s (sitting to supine) and ∼30 s (prone to supine).